567 related articles for article (PubMed ID: 32429195)
1. Connecting the Dots Between Inflammatory Bowel Disease and Metabolic Syndrome: A Focus on Gut-Derived Metabolites.
Verdugo-Meza A; Ye J; Dadlani H; Ghosh S; Gibson DL
Nutrients; 2020 May; 12(5):. PubMed ID: 32429195
[TBL] [Abstract][Full Text] [Related]
2. Gut Microbial Metabolite-Mediated Regulation of the Intestinal Barrier in the Pathogenesis of Inflammatory Bowel Disease.
Iyer N; Corr SC
Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959809
[TBL] [Abstract][Full Text] [Related]
3. Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System.
Postler TS; Ghosh S
Cell Metab; 2017 Jul; 26(1):110-130. PubMed ID: 28625867
[TBL] [Abstract][Full Text] [Related]
4. The role of the microbiome in gastrointestinal inflammation.
Sanders DJ; Inniss S; Sebepos-Rogers G; Rahman FZ; Smith AM
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34076695
[TBL] [Abstract][Full Text] [Related]
5. Epigenome-metabolome-microbiome axis in health and IBD.
Amatullah H; Jeffrey KL
Curr Opin Microbiol; 2020 Aug; 56():97-108. PubMed ID: 32920333
[TBL] [Abstract][Full Text] [Related]
6. The gut microbiome and metabolic syndrome.
Dabke K; Hendrick G; Devkota S
J Clin Invest; 2019 Oct; 129(10):4050-4057. PubMed ID: 31573550
[TBL] [Abstract][Full Text] [Related]
7. Molecular and Pathophysiological Links between Metabolic Disorders and Inflammatory Bowel Diseases.
Hyun CK
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502047
[TBL] [Abstract][Full Text] [Related]
8. Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease.
Agus A; Planchais J; Sokol H
Cell Host Microbe; 2018 Jun; 23(6):716-724. PubMed ID: 29902437
[TBL] [Abstract][Full Text] [Related]
9. NLRX1 Modulates Immunometabolic Mechanisms Controlling the Host-Gut Microbiota Interactions during Inflammatory Bowel Disease.
Leber A; Hontecillas R; Tubau-Juni N; Zoccoli-Rodriguez V; Abedi V; Bassaganya-Riera J
Front Immunol; 2018; 9():363. PubMed ID: 29535731
[TBL] [Abstract][Full Text] [Related]
10. Gut-Liver Physiomimetics Reveal Paradoxical Modulation of IBD-Related Inflammation by Short-Chain Fatty Acids.
Trapecar M; Communal C; Velazquez J; Maass CA; Huang YJ; Schneider K; Wright CW; Butty V; Eng G; Yilmaz O; Trumper D; Griffith LG
Cell Syst; 2020 Mar; 10(3):223-239.e9. PubMed ID: 32191873
[TBL] [Abstract][Full Text] [Related]
11. Intestinal alkaline phosphatase: a summary of its role in clinical disease.
Fawley J; Gourlay DM
J Surg Res; 2016 May; 202(1):225-34. PubMed ID: 27083970
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Regulation of Group 3 Innate Lymphoid Cells and Their Role in Inflammatory Bowel Disease.
Song D; Lai L; Ran Z
Front Immunol; 2020; 11():580467. PubMed ID: 33193381
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota: sculptors of the intestinal stem cell niche in health and inflammatory bowel disease.
Markandey M; Bajaj A; Ilott NE; Kedia S; Travis S; Powrie F; Ahuja V
Gut Microbes; 2021; 13(1):1990827. PubMed ID: 34747326
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiome in chronic rheumatic and inflammatory bowel diseases: Similarities and differences.
Salem F; Kindt N; Marchesi JR; Netter P; Lopez A; Kokten T; Danese S; Jouzeau JY; Peyrin-Biroulet L; Moulin D
United European Gastroenterol J; 2019 Oct; 7(8):1008-1032. PubMed ID: 31662859
[TBL] [Abstract][Full Text] [Related]
15. Correlation of diet, microbiota and metabolite networks in inflammatory bowel disease.
Weng YJ; Gan HY; Li X; Huang Y; Li ZC; Deng HM; Chen SZ; Zhou Y; Wang LS; Han YP; Tan YF; Song YJ; Du ZM; Liu YY; Wang Y; Qin N; Bai Y; Yang RF; Bi YJ; Zhi FC
J Dig Dis; 2019 Sep; 20(9):447-459. PubMed ID: 31240835
[TBL] [Abstract][Full Text] [Related]
16. Dietary Supplementation with Vitamin D, Fish Oil or Resveratrol Modulates the Gut Microbiome in Inflammatory Bowel Disease.
Wellington VNA; Sundaram VL; Singh S; Sundaram U
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008631
[TBL] [Abstract][Full Text] [Related]
17. Systematic assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic capabilities in inflammatory bowel disease.
Heinken A; Ravcheev DA; Baldini F; Heirendt L; Fleming RMT; Thiele I
Microbiome; 2019 May; 7(1):75. PubMed ID: 31092280
[TBL] [Abstract][Full Text] [Related]
18. Role of intestinal microbiota and metabolites in inflammatory bowel disease.
Dong LN; Wang M; Guo J; Wang JP
Chin Med J (Engl); 2019 Jul; 132(13):1610-1614. PubMed ID: 31090547
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiome of a porcine model of metabolic syndrome and HF-pEF.
O'Donovan AN; Herisson FM; Fouhy F; Ryan PM; Whelan D; Johnson CN; Cluzel G; Ross RP; Stanton C; Caplice NM
Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H590-H603. PubMed ID: 32031871
[TBL] [Abstract][Full Text] [Related]
20. Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases.
Aden K; Rehman A; Waschina S; Pan WH; Walker A; Lucio M; Nunez AM; Bharti R; Zimmerman J; Bethge J; Schulte B; Schulte D; Franke A; Nikolaus S; Schroeder JO; Vandeputte D; Raes J; Szymczak S; Waetzig GH; Zeuner R; Schmitt-Kopplin P; Kaleta C; Schreiber S; Rosenstiel P
Gastroenterology; 2019 Nov; 157(5):1279-1292.e11. PubMed ID: 31326413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
